Literature DB >> 7966909

Chronic abuse of zolpidem.

C A Gericke, A C Ludolph.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7966909     DOI： 10.1001/jama.1994.03520220015010

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

Review 1.  Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey.

Authors:  Caroline Victorri-Vigneau; Eric Dailly; Gwenaëlle Veyrac; Pascale Jolliet
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

2.  Sleep-stabilizing effects of E-6199, compared to zopiclone, zolpidem and THIP in mice.

Authors:  Chloé Alexandre; Alberto Dordal; Ramon Aixendri; Antonio Guzman; Michel Hamon; Joëlle Adrien
Journal:  Sleep       Date:  2008-02       Impact factor: 5.849

Review 3.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

Review 4.  Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

Authors:  K J Holm; K L Goa
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

Review 5.  Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.

Authors:  Romy Hoque; Andrew L Chesson
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

6.  The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: comparison with diazepam.

Authors:  Brittany T Wright; Catherine F Gluszek; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-15       Impact factor: 4.530

7.  'Z-trip'? A Comprehensive Overview and a Case-series of Zolpidem Misuse.

Authors:  Laura Orsolini; Stefania Chiappini; Paolo Grandinetti; Angelo Bruschi; Roberta Testa; Alessandra Provenzano; Domenico De Berardis; Umberto Volpe
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-05-31       Impact factor: 2.582

8.  Suspected Agomelatine-induced restless legs syndrome: a case report.

Authors:  Mustafa Abdul Karim; Nadeen Al-Baz; Sami Ouanes; Majid Alabdulla; Peter M Haddad
Journal:  BMC Psychiatry       Date:  2021-04-07       Impact factor: 3.630
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.